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Aim: To explore HIV-positive drug users’ experiences of taking antiretroviral medications in 
Taiwan, and further develop a conceptual model that can be used to understand their 
adherence to the long-term treatment. 
Background: The global vision of ending AIDS by 2030 cannot be achieved without 
addressing HIV-positive drug users’ experience of taking antiretroviral treatment. There 
remains a paucity of qualitative evidence on HIV-positive drug users’ experiences of taking 
antiretroviral medications globally and in East Asia. Nurses play a key role in supporting HIV-
positive drug users throughout their treatment process. Therefore, it is pivotal to understand 
HIV-positive drug users’ experiences of managing long-term anti-HIV treatment. 
Design: This qualitative study drew on a constructivist grounded theory approach to achieve 
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conducted in Taiwan between September 2015 and July 2016. Data were analysed using 
Charmaz’s coding principles. The integration and formation of the model began with focused 
coding and proceeded through the subsequent analytic process. The reporting of this study 
was based on the Consolidated Criteria for Reporting Qualitative Research (COREQ) 
checklist. 
Results: This study shows that integrating HIV-positive identity into sense of self laid a solid 
foundation for the acceptance of self and antiretroviral treatment. Valuing of antiretroviral 
treatment played a central role in driving their medication-taking behaviour. While valuing the 
treatment appeared to drive participants’ behavioural change, data revealed that conscious 
engagement was an important element for their behaviour maintenance.  
Conclusion: The evidence from this study can extend our knowledge of the mechanisms 
that influence the change and maintenance of HIV-positive drug users’ adherence to 
antiretroviral treatment.  
Relevance to clinical practice: The Identity-Value-Conscious engagement Model 
developed and proposed in this study can serve as a guide for the development of tailored 
adherence assessment and associated nursing interventions for this population. 




The Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2014 set out a goal to end 
Acquired Immunodeficiency Syndrome (AIDS) by 2030. To reach this global visionary goal, it 
is widely recognised that more than 95% of prescribed Highly Active Antiretroviral Therapy 
(HAART) medications should be taken for complete viral suppression (World Health 
Organisation (WHO), 2013). However, a growing body of evidence indicates that HIV-
positive drug users are less likely to access HIV care and adhere to treatment regimens 
compared to other HIV subgroups (Ware, Wyatt, & Tugenberg, 2005; Wasti, Simkhada, 
Randall, Freeman, & van Teijlingen, 2012). Suboptimal adherence can lead to opportunistic 
infections, drug resistance, and limited treatment options (Lima et al., 2008; Meresse et al., 
2014). In HIV-positive drug users, Tuberculosis is particularly common as a result of poor 
adherence (WHO, 2017).  It is therefore important to understand the mechanisms that 
support HAART adherence in HIV-positive drug-using populations in order to promote 
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Research to date has tended to focus on measuring the rates of drug users’ adherence to 
HAART rather than gaining insight into the mechanisms underlying their HAART-taking 
behaviour (Mann et al., 2012; Authors, 2019; Waldrop-Valverde, Dong, & Ownby, 2013). 
There remains a paucity of qualitative evidence on HIV-positive drug users’ experiences of 
taking HAART globally. Only 11 qualitative studies from USA, Canada, Russia, Ukraine, 
Spain and India were identified prior to this study (Chakrapani et al., 2014; Batchelder et al., 
2013; de la Hera, Davo, Ballester-Añón, & Vioque, 2011; McNeil et al., 2017; Mimiaga et al., 
2010; Pach, Cerbone, & Gerstein, 2003; Rhodes & Sarang, 2012; Small, Wood, Betteridge, 
Montaner, & Kerr, 2009; Ware et al., 2005, Witteveen & Ameijden, 2002). 
A multitude of factors have been identified in the aforesaid 11 studies to influence their 
adherence to HAART, including stigmatisation, active drug use, motivation, side effects of 
HAART, accessibility, health care professionals’ attitude towards drug users, and 
forgetfulness (Chakrapani et al., 2014; Batchelder et al., 2013; de la Hera, Davo, Ballester-
Añón, & Vioque, 2011; McNeil et al., 2017; Mimiaga et al., 2010; Pach, Cerbone, & Gerstein, 
2003; Rhodes & Sarang, 2012; Small, Wood, Betteridge, Montaner, & Kerr, 2009; Ware et 
al., 2005, Witteveen & Ameijden, 2002). Whilst these studies provide insight into the factors 
that can influence HIV-positive drug users’ adherence to HAART, the findings tend to be 
descriptive in nature and little is known about the mechanisms that influence their adherence 
through a theoretical lens. Uncertainty still exists about the interrelationships between the 
factors that impact adherence, and how the factors collectively or interactively influence drug 
users’ HAART-taking behaviour. This formed the basis of the research inquiry for this study 
in respect to developing a theoretical understanding of HIV-positive drug users’ HAART-
taking behaviour.  
Health behaviour theories/models 
To date, several theories have been developed and applied to explain personal and social 
determinants of behaviour and to guide and refine health-related interventions (Munro, Lewin, 
Swart, & Vomink, 2007), such as the Health Belief Model (Rosenstock, Strecher, & Becker, 
1994), Theory of Planned Behaviour (Ajzen 1991), Social Cognitive Theory (Bandura, 1991 
and 2001), Information-Motivation-Behavioural skills Model (Fisher & Fisher, 1992), and 
Motivation Protection Theory (Weinstein, 1993). Of these theories/models, Information-
Motivation-Behavioural skills Model is the only model that has been extensively employed in 
research to explain HIV-positive individuals’ adherence to antiretroviral treatment (Fisher, 
Fisher, Amico, & Harman, 2006; Amiko, Toro-Alfonso, & Fisher, 2005). However, this model 
does not provide adequate theoretical explanations regarding how motivation is defined and 











This article is protected by copyright. All rights reserved 
health behaviour theories/ models, there is an increased recognition of similar and 
overlapping constructs. For instance, the Health Belief Model, Information-Motivation-
Behavioural Skills Model, Motivation Protection Theory, Theory of Planned Behaviour, Social 
Cognitive Theory all provide a cost-benefit analysis component in which an individual weighs 
pros and cons of an action and then leads to motivation for (not) taking the action. Whilst the 
theories and models provide theoretical implications of what can trigger individual behaviour, 
one’s decision to take an action is not always rational and intentional but could be 
emotionally triggered, unintentional and context-specific.  
HIV and drug use, for instance, have been associated with behaviours or characteristics that 
are deviant from social norms, such as promiscuity, crime, sex work, and homosexuality 
(Logie, James, Tharao, & Loutfy, 2011). These historic associations could lead people to 
generate negative impressions and prejudice towards HIV-infected drug users. When these 
discrediting attributes are incongruous with the stereotype of what a given type of individual 
should be, stigma could occur (Goffman, 1963). Affected individuals’ experiences of 
intersectional stigma could exert significant social and psychological effects (Goffman, 1963). 
For instance, in a cross-sectional study by Nachega et al. (2012), it was reported that 
depression, isolation, non-disclosure of HIV status and stigma/descrimination were 
significantly common among people living with HIV. In particular, Asia-Pacific region had the 
highest rate of perceived stigma (71%) compared to Europe (49%), North America (41%), 
Africa (41%) amd Latin America (29%) (Nachega et al., 2012). In the same vein, Charles 
Cooley (1983) in his looking-glass theory encapsulated the idea that our sense of self, of 
who we are, is intimately shaped by those around us, by our emotions and by perceived 
judgement; therefore, suggesting that it changes depending on which society we grow up in 
and situate ourselves. When confronting a sudden or stigmatised illness, affected individuals 
could reflexively interpret the illness that is bestowed upon them by others and themselves, 
leading to change in their sense of self (Pierce, Kostova, & Dirks, 2003). Illness experience 
was proposed by Karnilowicz (2011) and Bury (1982) as an epiphany that could alter an 
individual’s fundamental meaning structures and result in reassessing his/her sense of self 
during the process of the illness. Nonetheless, identity theories have not been incorporated 
into health behaviour theories/models. To avoid theory duplicates and drive new 
development, we drew on Charmaz’s (2014) grounded theory approach to develop a 
conceptual model that can be used to enhance understanding HIV-positive drug users’ 
treatment-taking behaviour. In this approach, theoretical sensitivity and abductive reasoning 
are the key features for checking all possible theoretical explanations by empirically 










This article is protected by copyright. All rights reserved 
adherence (Charmaz, 2014). The development of a model in this study is to inform practice 
and to advance nursing science in HIV care.  
Methods 
The Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist was used 
to report this qualitative study (See Supplementary File 1). 
Aims and questions 
In this study, we set out to explore HIV-positive drug users’ experiences of taking HAART, 
and to develop a conceptual model for unpacking the complexity of their HAART-taking 
behaviour. 
The research questions that we sought to answer were: 
Main research question: 
What are the experiences of taking HAART among HIV-positive drug users in Taiwan? 
Sub-questions: 
1. What meanings do HIV-positive drug users attribute to their experiences of taking HAART? 
2. What is the process of their HAART-taking behaviour?  
3. What contributes to the stability and change of HIV-positive drug users’ HAART-taking 
behaviour? Under what conditions? 
Overall study design 
This qualitative study took a social constructionist perspective (Denzin & Lincoln, 2018), and 
drew on a constructivist grounded theory approach that was consistent with the aim of 
developing a conceptual model (Charmaz, 2014). Knowledge was therefore conceptualised 
as interpretive and contextually situated (Charmaz, 2014). With its focus on the subjective 
and situated construction of experience, this approach provided a useful means for 
understanding drug users’ experiences of taking HAART. 
Study settings   
Taiwan is a highly collective and hierarchical society (Zhang, Lin, Nonaka, & Beom, 2005). 
Such collectivism and hierarchy had an impact on facilitating and limiting access to study 
sites. In an attempt to gain support and access to study sites, a networking strategy was 
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professionals by a colleague who worked in the HIV field in Taiwan. By using this approach, 
colleagues at the study sites agreed to support this study and recruitment. The chain of 
social relations was built through the process of constant negotiation and interaction with 
stakeholders, resulting in gaining access to study sites.  
Twenty-two HIV-positive drug users were recruited from three sites in Taiwan that provide 
HIV and addiction services to people who use drugs and are living with HIV: 1) HIV 
outpatient settings at a large hospital in Taiwan, 2) a non-government HIV association 
(operated in two capital cities in Taiwan), and 3) an addiction support association (multiple 
branches across Taiwan). The rationale for recruiting through multiple sites was to access 
the experience of a diverse range of people who use drugs and are living with HIV in Taiwan. 
Recruitment and sampling  
The criteria presented in Table 1 were to identify suitable participants and meet the research 
aims (Table 1: Inclusion and exclusion criteria). 
Participants were recruited through health and social care professionals. During the 
recruitment period, health and social care professionals provided prospective participants 
with study information sheets and then gave them 1-3 weeks to think whether they would like 
to take part. If prospective participants were interested in the study, the researcher (SSH) 
would be introduced to the potential participants by health and social care professionals. 
This strategy was used in an attempt to enhance voluntary participation and to provide them 
with an option of not disclosing their contact information. 
In total, there were 22 HIV positive drug users were recruited into the study, including 18 
men of which 11 identified themselves as homosexual, 1 bisexual, 7 male heterosexual IDUs, 
and 3 female heterosexual IDUs (Table 2: Socio-demographic information). This is how 
the participants perceived to have contracted the virus. In Taiwan, HIV-positive drug users 
were mainly classified into two subgroups based on the transmission route—MSM (65% of 
the total HIV population, n=25,770) and IDUs (20% of the total, n=7,059) (CDC, 2020). In 
this study, the MSM group were infected with HIV through homosexual contact and used 
stimulants mainly for recreational purposes; the IDUs group were infected with HIV through 
sharing injecting equipment and were heroin injectors. In terms of gender, in Taiwan, males 
constitute 94.72% (n=37,573) of the total HIV population (n=39,669) (CDC, 2020). On the 
other hand, there were only 921 HIV-positive female drug users across Taiwan (CDC, 2020), 
which might include those in jail, those not receiving HAART, and those not in the 
recruitment sites. Concerned about the nature of illegal drug use, HIV stigma and social 
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recruiting female IDUs living with HIV in this study. Nevertheless, based on the HIV 
epidemiology in Taiwan, we would regard our study sample was the proportionality of the 
HIV population. Non-participation cases are listed in Table 3. 
The sampling method for this study started with convenience sampling, and then moved to 
purposive sampling. The initial phase of convenience sampling was to gain insight into 
participants’ experiences. Following the initial sampling and data analysis, sampling criteria 
for people, situations and settings were established for the following rounds of purposive 
sampling (Charmaz, 2014). For instance, four characteristics of the participants were 
identified during the process of data collection and analysis to influence their HAART-taking 
behaviour— Transmission route (unprotected sex or intravenous drug use), drug-using 
dynamics (heavy drug use or occasional drug use), gender, and the length of being 
diagnosed with HIV and on HAART (Table 2). These characteristics were then taken into 
account when framing sampling criteria during the data collection process.  
Once tentative ideas about the data were developed, the later rounds of purposive sampling 
were to explicate and fill the incomplete categories. The incomplete categories meant that 
there remained some questions that did not give complete details of the categories, such as 
processes, behaviour patterns, outcomes, and contingencies.   
The decision to stop data collection was made based on no additional questions (incomplete 
categories) and new theoretical insights found during the data collection period (September 
2015 - July 2016).  
Data collection   
To facilitate the collection of rich data, face-to-face semi-structured in-depth interviews were 
conducted by SSH in Mandarin at a meeting room of the hospital or of the associations. The 
interview locations were chosen by participants due to a sense of security given by these 
trusting and familiar places. The interviews in this study were to explore participants’ 
experiences of being HIV positive, taking HAART, and illicit drug use, all of which were 
potentially sensitive topics. Given the sensitive nature of the research, one-to-one interviews 
provided a more private and secure space for participants to share their personal experience 
than other data collection options such as focus groups.  
Interview questions for this study were open-ended, general, and focused on the central 
phenomenon relating to HIV, HAART taking, and illicit drug use (Table 4: Interview guide).  
As the interview progressed, the interview questions were revised or added to depending on 
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Translation 
Translation of research data and findings between two different languages involves 
interpretation. To capture the meanings behind participants’ stories and avoid loss of 
meanings, SSH analysed data in Mandarin. Once subcategories and categories in Mandarin 
were developed, the coded data were translated into English and then the data in English 
were re-analysed to develop codes, subcategories, and categories in English. The Mandarin 
and English versions of data, codes, subcategories and categories were compared to see 
their similarities and differences. Throughout the process, SSH moved back and forth 
between translation and data analysis and discussed the findings with RS and AH to develop 
a meaning-based translation. The detailed information with regard to the translation 
procedure of this study and the researcher’s role during translation and data analysis is 
written in the paper by Authors (2019). 
Data analysis  
This study followed Charmaz’s (2014) coding principles, which consist of two phases — an 
initial coding phase and a focused coding phase. An initial phase of coding involved line-by-
line coding, and segment-by-segment coding. At this phase, the first author was open to all 
possible directions indicated by the data being read, and coding was named as close to the 
data as possible. In focused coding, similar codes were assembled together to analyse their 
commonalities, and then we attributed meanings to the organisation and layered the analysis 
into increasing levels of abstraction (codes -> subcategories -> categories -> concepts -> the 
interrelationship of the concepts -> a larger conceptual model) (Table 5: Concept mapping). 
The analytic process involved induction (grounded from the data), deduction (authors’ 
interpretations) and abduction (comparing and contrasting the findings with the existing 
theories and knowledge). These are essential steps of developing a theory/model in 
Charmaz’s constructivist grounded theory (Charmaz, 2014). 
Throughout the research process, two analytic techniques, constant comparison and memo 
writing (observational notes and analytic journals), were used to help capture the 
connections of data and codes across cases, and to crystallise questions and directions for 
further exploration. This study used NVivo software (version 10 and 11) to organise data and 
codes.  
Trustworthiness 
To ensure the trustworthiness of this study, we used excerpts from participants’ interview 
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including interview data, socio-demographic information, observation notes, and research 
memos. Comparing different types of data during the analysis allowed to open up a more 
complex and in-depth understanding of participants’ experiences. In addition, any 
uncertainties and questions that arose during the study period were discussed within the 
team to enhance the transparency of this study and minimise biases. To deeply explore 
participants’ experiences and understand the meanings behind their stories, it was important 
to establish rapport with them. During data collection, our study participants were treated 
with respect, dignity and non-judgemental attitude. With their trust in the team, they 
appeared to openly share their experiences with us, which helped to enhance the credibility 
of the findings.  
Ethical considerations 
This study was approved by the ethics research committees of a teaching hospital in Taiwan 
(201507053RINA) and a Higher Education Institution in the UK (NURS011). 
Prospective participants were provided with study information sheets regarding the purposes 
of this study, study procedure, participants’ rights, data management and study contributions. 
Taking part in this research was completely voluntary. Participants were informed that they 
could withdraw at any time. Due to the sensitive research topic, all of the data were 
anonymised during transcription (by the first author). The data files were encrypted and 
saved on the university server, and the hard copies were securely kept in the locker of a 
secured university office.  
Results 
HIV-positive identity as part of self-identity, values attached to HAART, and conscious 
engagement emerged from the analysis to influence participants’ HAART-taking behaviour.  
Integrating HIV-positive identity into sense of self was revealed in the analysis to lay a 
foundation for HIV-positive drug users to accept themselves as HIV positive and the 
treatment. Valuing HAART appeared to play a central role in directing and driving their 
HAART-taking behaviour. Conscious engagement surfaced in the analysis to influence their 
maintenance of HAART-taking behaviour. 
HIV-positive identity as part of self-identity (Figure 1) 
HIV is a chronic and long-term health condition. In this study, many participants found it 
difficult to reconcile their sense of self with the implications of being HIV positive upon 
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status into their self-identity, and this in turn made them more accepting of antiretroviral 
treatment.    
Non-integrated self-identity 
HIV infection was viewed negatively by many participants. When not accepting HIV as part 
of HIV-positive self-identity, they were inclined to feel ashamed and not disclose their HIV 
status; thereby it could be proposed that this undermined their internal strength to manage 
HIV and its treatment. 
“Getting HIV meant that my life was ruined, because when I was little, ads said that 
HIV infection was caused by promiscuity. The ads educated us to not have sex with 
many people and to remember wearing condoms; otherwise, you would get HIV… 
That’s why I felt HIV was a shameful disease.” (P10, Female heterosexual, 33y) 
“The public thinks that HIV means gay men. I also think so. There is a reason behind it. 
You can see that why HIV incidence among heterosexuals is so low. There must be a 
reason behind it.” (P1, MSM, 28y) 
Data revealed that HIV was portrayed as being associated with other attributes, such as 
promiscuity, homosexuality, and illicit drug use. This indicates that public perceptions of HIV 
surfaced mainly in respect to the ways affected individuals were infected. The multi-layered 
and negative social images of HIV were revealed within the analysis to influence the way 
participants evaluated themselves as HIV positive. For example, participants’ statements “I 
felt HIV was a shameful disease” (P10, female heterosexual, 33y), “It is awful even just hear 
this word” (P15, Male heterosexual, 53y), and “It is a shameful disease” (P16, male 
heterosexual, 42y) conveyed their feelings of shame by carrying the stigmatizing HIV-
positive identity. When participants’ emotions towards “stigmatising HIV” were overpowering, 
the amount of knowledge they have learned relating to HIV was completely subsumed. This 
is exemplified by P2’s and P19’s stories. 
“HIV is a chronic illness. If not controlling it well, it can develop AIDS. If it is controlled 
well by medications, we can live longer. It is just a statement. You feel like you still live 
with it day by day.” (P2, MSM, 32y) 
“It is social value. While current medical technology is advancing, HIV is just a chronic 
disease, however, when it comes to social value, I think how to solve the issue of HIV 
stigma becomes difficult and unanswerable.” (P19, Male heterosexual, 43y) 
Participants who perceived themselves negatively were inclined to lose their sense of self 
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“I felt ashamed of myself and avoided the crowd, starting to lose the sense of 
myself…Cocktail treatment is equated with HIV. It is the same thing. Most people 
wouldn’t reveal what they are taking. I rarely saw people who took antiretroviral 
treatment. Even though they took it, they wouldn’t reveal they were taking the 
medications. They wanted to save face. It’s common in the Taiwanese society.”(P7, 
MSM, 30y) 
“They [medications] reminded me that I had problems in my body. This would affect 
my regular use of medications. I think that you may have heard other people viewed 
the treatment negatively and had many negative emotions. It just reminded me that I 
have HIV.” (P12, MSM, 35y) 
Living in the Taiwanese society where the image of HIV was negatively portrayed, most 
participants felt afraid and insecure to disclose their HIV status. This imposed limitations on 
them and created a barrier between self and others. As a result, not disclosing HIV 
increased participants’ emotional burden and negatively affected their management of HIV 
and HAART.  
“People don’t know my condition and I need to conceal. I just don’t want to explain to 
others what medications I am taking.” (P18, Female heterosexual, 32y) 
“Not many people would take the medications openly. To me, I cannot do it. I will try to 
avoid the risk. I’ve never taken my medications outside.” (P1, MSM, 28y) 
By and large, participants’ HIV-positive identity appeared to undermine their self-acceptance 
of what they were and further influence their readiness and willingness of initiating and 
receiving HIV treatment. 
Integrated self-identity 
Participants, on the whole, demonstrated that their integration of HIV identity into their sense 
of self assisted them in viewing their HIV status more positively, and increased their 
willingness to face and manage HIV and HAART. 
“I have gone through everything. It’s important to be positive…I think it still depends on 
self.” (P4, MSM, 26y) 
In P4’s account, his acceptance of the HIV-positive identity appeared to involve process and 
his experiential learning. Through reflecting on his HIV journey and finding meanings in his 
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“The scar will be there with you for the rest of your life. It depends on how you view it. 
If I think it is a scar on my face, I wouldn’t get along with it well. If I think it is part of my 
body, I would try to make it pretty or cover it up. It depends on yourself.” (P13, MSM, 
31y) 
Participant 13 used ‘scar’ as a way to describe the perceived negative label of his HIV-
positive identity. His self-acceptance did not mean he liked what was happening but once he 
gave up the resistance and denial, he took the energy he was struggling and used it to 
manage HIV more wisely. His positive thinking and emotional adjustment seemed to have 
aided in treatment management. 
In addition, a feeling of being supported was stated by some participants to provide a source 
of comfort in their troubled times, as well as a foundation for feeling unconditionally valued, 
loved and cared for.  
“During this process, the HIV specialist always encourages me. I can feel the support. I 
feel thankful. I will bravely keep moving on. I need to take the responsibility of my life. 
Although it is painful to have HIV, this medical team is my only motivator to move 
forward.” (P2, MSM, 32y) 
Participants’ statements as below illustrated that by feeling supported and finding meaning in 
life it seemed to motivate them and facilitate their willingness to face HIV and manage 
HAART— “That’s when they [family] reminded me to take medications. It was a big 
encouragement. They want me to live” (P12, MSM, 35y), and “This faith [Christianity] has 
greatly influence my regular use of medications” (P4, MSM, 26y). 
Values attached to HAART taking (Figure 2) 
Valuing HAART emerged from our analysis as central to participants’ HAART-taking 
behaviour. In this study, the degree to which participants valued HAART greatly influenced 
their motivation and engagement with HAART-taking. 
Placing low values on HAART taking 
Where participants placed low values on HAART this governed their state of motivation and 
HAART-taking behaviour. Placing such low values on regular HAART use was shaped by 
the degree to which participants believed in the importance of regular HAART use. 
“Sometimes when I was sleepy, I would feel lazy to get up to take medications. I 
thought it was fine to take them next day. It doesn’t happen frequently, less than 3 
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“I had treatment interruption because I was laid back. Hence I didn’t go to 
hospital…Also, at that time my CD4 cell count was fine, at around 500. I thought it was 
fine to stop the treatment.” (P16, Male heterosexual, 42y)  
P6 has taken antiretroviral medications for 15 years and is a relative adherer, whereas data 
showed that he intentionally skipped doses sometimes. His statements— “it was fine to take 
them next day” and “I don’t care” indicated that skipping doses few times did not concern 
him. Congruent with P6, P16’s statements showed that his interpretations of the need for 
taking HAART and his laid-back approach influenced his medication-taking behaviour and 
led to treatment interruption for two years. 
The values participants placed on HAART consist of cognitive, affective, motivational, and 
behavioural components. A cognition that involved interpretation and developed a conceived 
value (e.g. “I thought it was fine”, P6, MSM, 52y), an affection that provided feeling about the 
object (e.g. “I don’t care”, P6, MSM, 52y), and a behaviour that was provoked when the 
value was activated (e.g. skipped doses). These were shaped through the process of 
participants’ experiences. When not thinking and feeling the importance of taking HAART, 
participants were less likely to value it and to take HAART regularly.  
In addition, for HIV-positive drug users, illicit drug use was found to influence the values they 
placed on HAART in two ways— Hierarchy of values (personal preference) and the impact 
of drug effects on changing personal values. 
“I often went out at midnight for having sex and using drugs. When having fun, I 
wouldn’t think of dosing times. I wouldn’t finish it within 3-5 hours.” (P1, MSM, 28y) 
“Some would just crave for that euphoric effect, and constantly inject drugs to sustain 
that kind of feeling…Then would neither care what time it was nor notice dosing times” 
(P18, female heterosexual, 32y) 
In P14’s and P15’s narratives, the psychoactive drugs they used affected their cognition, 
causing them to rationalise their drug-taking behaviour and to undermine their self-
awareness. 
Because using drugs could distort my values and my worldviews. They were all 
changed and distorted. I wouldn’t care about my health.” (P15, Male heterosexual, 53y) 
“When using a lot of drugs and for a long period of time, we would not have self-
awareness. We wouldn’t think of whether we needed to maintain health. I would feel 
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To sum up, it seems that participants prioritised what was important to them based on their 
beliefs and preferences. When valuing illicit drugs more than HAART, some were inclined to 
use drugs and intentionally ignore dosing times. On the other hand, the effects of illicit drugs 
on participants’ cognition and emotion also influenced the values they placed on taking 
HAART. 
Developing the values of taking HAART 
From our analysis, we found that some participants began to value HAART through their 
acknowledgment on the benefits of taking HAART and the impact of erratic HAART use. 
Furthering this notion, their personal experiences emerged in the analysis to reinforce 
participants’ motivation.  
“HAART has increased my CD4 cell count, boosted my immune system, and made my 
viral load undetectable. This is a big motivator for me.” (P2, MSM, 32y) 
“It is better to not stop the treatment because it could cause drug resistance. If it 
happens, there won’t be any treatment available for me. “ (P4, MSM, 26y) 
Participants’ narratives provide a sense that their acknowledgement of the pros and cons of 
receiving treatment influenced their perception and motivation. In addition to their 
acknowledgement, the desire to live longer and to take HAART was formed through 
participants’ social relationships. 
“I take the medications because my thought has been changed. Nowadays HIV is not 
that horrible and also I have a son. I want to live longer and see him grow up and have 
his own family.” (P15, Male heterosexual, 53y) 
“I want to live. I don’t want to let my family down.” (P11, MSM, 31y) 
In particular, participants’ feelings of support from family had given them hope and 
aspirations to live, thereby they valued HAART and felt motivated to regularly take the 
medications. 
Conscious engagement (Figure 3) 
Valuing HAART acted as a driving force to direct participants’ HAART-taking behaviour. 
However, data revealed that to strictly follow a prescribed HAART regimen, participants 
needed to make a conscious effort and be mindful of their engagement with the treatment in 
the present moment and under the given situation. 
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Participants’ narratives demonstrate that the majority of them had forgetten to take HAART 
regimens at some point during their treatment trajectory. Their forgetfulness was found to be 
linked to their lack of conscious engagement in taking HAART at dosing times and in 
particular situations.  
“When I watched movies, I didn’t notice my pill box, and the dosing time passed…If 
you didn’t notice it, you would forget. The next day, when I opened my pill box, I found 
out that I hadn’t taken my dose yesterday.” (P6, MSM, 52y) 
P6’s statement indicates how he lost track of dosing times. Without consciously engaging in 
taking HAART, some participants were less able to attend to and exercise control over their 
HAART-taking behaviour, leading to unintentionally missing doses. 
“When I got back in the evening, I was tired. In other words, after taking a shower, I 
would want to sleep right away and then I forgot my doses. This incidence is rare, less 
than one time every 2-3 months.” (P8, Male heterosexual, 49y) 
In addition, without establishing a lifestyle that incorporated HAART into routines, 
participants, on the whole, demonstrated that the level of their conscious engagement with 
the treatment was lowered. 
“If I am on a business trip for 1 or 2 nights, I would sometimes forget to take the 
medications with me. If I remember I would bring them. If I forgot, I would take it next 
day.” 
The excerpts from participants’ interview transcripts — ‘too many things’ and ‘busy at work’, 
point that participants’ involvement in other activities shifted their focus onto matters of 
concern other than HAART regimens, and increased the likelihood of missing doses.  
Consciously engaging with HAART taking 
From the analysis, we found that when participants took control over their behavior and 
external influences, they were more likely to manage long-term antiretroviral treatment more 
effectively. Participants’ conscious engagement with the treatment involved a controlled and 
intentional process where they could reflect upon mental activity and foster self-control and 
self-adaptation so as to fit dosing schedules into their lives.  
“Using drugs wouldn’t affect my regular use of medications…As I mentioned earlier, 
you should know how to engage in chemsex and how to control self and not to be 
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Drawing on participants’ experiences, their self-control over drug use had helped to optimise 
their adherence to HAART. Self-control involved perseverance. The word — ‘must’, used by 
P10, conveys a sense of determination to continue regularly taking HAART. 
“I know I must take the medications. I always tell myself I must take medications and I 
cannot miss doses.” (P10, Female heterosexual, 33y) 
In terms of adaptation, throughout the treatment process many participants were able to 
apply cognition and reason to develop strategies and adjust behaviour so as to take HAART 
regularly.  
 “I found that when I had the medications after my first bite of the meal, I would feel 
fine. I found this strategy.” (P12, MSM, 35y) 
“I usually use phone alarms to remind myself of taking medications. When it rang, I 
would take the medications.” (P17, Male heterosexual, 37y) 
In addition to the above, other strategies shared by participants included linking dosing times 
with daily schedules (P7, P20, and P21), placing medications at a visible place (P19, P22), 
using a pill box (P6 and P15), or significant others’ reminders (P10 and P8). 
By and large, participants who adhered to HAART in this study tended to have a heightened 
sense of situational awareness in relation to taking HAART, and were willing to exert 
cognitive efforts for regular HAART use. 
Discussion 
Three major concepts emerged in the analysis to influence HIV-participants’ treatment-taking 
behaviour: 1) HIV-positive identity as part of self-identity, 2) Values attached to HAART, and 
3) Conscious engagement. The three concepts were integrated into a conceptual model to 
understand participants’ behaviour change and maintenance— Identity-Values-Conscious 
Engagement Model (Figure 3). This proposed model suggests that individuals’ integration of 
HIV-positive identity into sense of self can provide a foundation for HIV-positive individuals to 
accept themselves and the antiretroviral treatment. Having this integrated identity, valuing of 
taking HAART plays a central role in driving and guiding their HAART-taking behaviour. 
While valuing HAART can trigger behavioural changes, we found that conscious 
engagement is an important element for sustaining their regular HAART use.  
Identity is defined by Sharma and Sharma (2010) as “an individual’s comprehension of him 
or herself as a discrete, separate entity (p.119).”  Self-identity is an ongoing process of 
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and social interactions (Karnilowicz, 2010; Stryker & Burke, 2000; Williams, 1984). In this 
study, participants’ negative perceptions of HIV were deeply grounded in social values, 
wherein HIV was negatively portrayed by the Taiwanese society. The new HIV-positive 
identity altered some of the participants’ fundamental meaning structures of what they are, 
leading to the uneasy balance between seeing HIV as an external force but yet feeling it 
affecting all aspects of their lives. On the other hand, with a coherent sense of self-identity, 
participants were more inclined to accept themselves and their treatment. These findings 
resonate with Baumeister’s (1999) concept of self-congruence. He contended that self-
acceptance and perceived acceptance from others can decrease internal conflicts 
(Baumeister, 1999), and thus enhance psychological well-being necessary to fulfil self-
integration into society, and provide a blueprint for the least conflicted plan of actions (Pierce 
et al., 2003).  This reflects the importance of continuing to decrease HIV-related stigma, 
through public health programmes and policies, and also to decrease stigma attached to the 
groups of individuals who are at an increased risk of HIV and marginalised within society 
such as homosexuality or intravenous drug users.  
In terms of values, the role of values in an individual’s health behaviour has not been 
extensively investigated in the current evidence base. Therefore, this study provides an 
important opportunity to advance the understanding of this concept and how it can influence 
individuals’ HAART-taking behaviour. Values emerged in our analysis to play a core role in 
driving participants’ HAART-taking behaviour. Values are defined, in this study, as a 
reflection of what an individual deeply believes to be important and necessary. Participants’ 
decision to regularly take HAART was centred around what mattered to them and what they 
wanted. This is the deep-seated values that drive and guide their HAART-taking behaviour. 
The concept of values in this study is similar to the concept of beliefs elucidated in the 
Health Belief Model by Rosenstock et al. (1994), and the concept of motivation/intention in 
Protection Motivation Theory by Weinstein (1993) and Theory of Planned Behaviour by 
Ajzen (1991). These concepts theorise how individuals’ perceptions of health and health 
behaviour can influence their motivation to act. However, the concepts of beliefs and 
motivation/intention elucidated by the aforementioned theories were in a sense of being led 
by rationality. Aside from rationality, individual preference/tendency was found in this study 
to shape the values participants placed on regular HAART use. Preference conveys an 
individual’s tendency to choice, leading to value hierarchy (Rokeach, 1973). The hierarchical 
order of individual values is proposed by Rokeach (1973) to steer sequences of an 
individual’s acts. In this study, participants tended to prioritise what was important to them. 
The more an object had value to the participants, the more they preferred it over the other 
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were in conflict, some were in favour of pursuing chemsex or injecting drugs but ignored 
HAART regimens. Therefore, the notion of “Values” developed in this study provides a 
deeper sense of beliefs that can drive individuals’ acts (Rokeach, 1973).  
To manage and sustain long-term and regular HAART use requires conscious behavioural 
control. Conscious engagement is referred to as a process where an individual reflectively 
and intentionally make regular HAART use possible and adapt to the external environment 
by fostering self-control and self-adaptation. The findings of this study suggest that without 
consciously engaging in HAART taking, participants tended to unintentionally forget and 
miss doses. This was especially common when participants were tired or busy. In addition, 
when heavily using drugs, many participants complained drug effects impaired their memory 
and levels of consciousness. These external influences undermined their ability to 
consciously manage HAART taking. These findings fit with existing evidence that HIV-
positive drug users were more likely to miss doses (de la Hera et al., 2011; Harzke et al., 
2004; Mimiaga et al., 2010; Witteveen & Ameijden, 2002). On the other hand, by consciously 
and strategically engaging in HAART taking, participants were able to adapt to the external 
influences and regularly take HAART. The concept of conscious engagement is grounded in 
the data and also inspired by the existing theories – Ajzen’s Theory of Planned Behaviour 
(1991) and Bandura’s Social Cognitive Theory (1991 and 2001) where the emphasis was 
placed on how individual behaviour can be regulated by self-consciousness and self-
monitoring. Congruently, the empirical literature also indicates that some HIV-positive drug 
users were able to develop strategies to manage HAART taking (Mimiaga et al., 2010; Ware 
et al., 2005; Witteveen & Ameijden, 2002). However, these empirical studies did not explore 
the mechanism that underpins their coping ability. Thus, the findings of this study add 
knowledge to fill the gap in the current evidence base and provide a more comprehensive 
understanding of HIV-positive drug users’ experiences of managing long-term antiretroviral 
treatment 
Conclusion 
To conclude, this study aimed to deeply explore HIV-positive drug users’ experiences of 
taking HAART in the Taiwanese context and subsequently develop a conceptual model 
based on their experiences. Though it has been documented that HIV-positive drug users 
were less likely to adhere to HAART compared to the general HIV population, the 
mechanisms underlying such behaviour remained unclear. This study advances our 
understanding of HIV-positive drug users’ HAART-taking behaviour through key insights into 
1) HIV-positive drug users’ contextually situated experiences of taking HAART in Taiwan, 2) 
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behaviour, and 3) the development of the Identity-Value-Conscious engagement Model that 
can be applied to understand HIV-positive drug users’ health behaviour changes and 
maintenance. 
Relevance to clinical practice 
This study has several implications. Firstly, within the HIV care continuum, nurses play a 
crucial role in supporting HIV-positive drug users during their treatment process, and often 
have a close connection to them.  Within this relationship it is important to address common 
barriers to taking HAART. At the beginning of HIV trajectory, many participants experienced 
emotional distress. This finding suggests that upon diagnosis of HIV, nurses need to pay a 
particularly close attention to HIV-positive drug users’ psychological well-being by eliciting 
HIV-positive drug users’ concerns, feelings, and perceptions of being HIV positive and taking 
HIV medications. This study offers evidence that patients’ sense of self can also be affected 
by the social context where feelings and thoughts arise. Thus, this study suggests that 
nurses should understand their support system, support them to develop strategies for HIV 
disclosure and acquisition of support, provide referrals to community support services, and 
be a moderator between clients and their families if they agree.  
Secondly, valuing HAART appeared to be the driver of HIV-positive drug users’ HAART-
taking behaviour. Nevertheless, helping HIV-positive drug users to begin to value HAART 
requires our patience and prolonged engagement with them, as it takes time for HIV-positive 
drug users to perceive the importance of regular HAART use, and to develop the mindset of 
valuing it. The meaning of regular HAART use is constructed through HIV-positive drug 
users’ interaction with others and how they perceive themselves and the world. Part of the 
treatment journey involves HIV-positive drug users’ gradual discovery and development of 
values attached to HAART. In that sense, it implies the importance of providing constant 
support to this group of the population with patience, non-judgemental attitude, and 
compassion. Thus, this study recommends nurses to regularly assess HIV-positive drug 
users’ needs, provide education and emotional support throughout the process of HIV care. 
Motivational interviewing techniques can be undertaken to enable clients to think through the 
pros and cons of regularly taking HAART, and peer support can be facilitated to provide 
practical issues they commonly encounter and strengthen their will to make behaviour 
changes.  
Concerning the need for long-term management of taking HAART, forgetting to take doses 
was common among HIV-positive drug users in this study. This was mainly attributed to their 
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or drug effects. To minimise external influences, the findings in this study suggest that 
nurses can support clients to identify situations where they would be more likely to forget 
taking doses, and to develop strategies that can help them effectively manage regular 
HAART use. 
While this study can make contributions to knowledge within the field of HIV, addiction, and 
behavioural research, there are two major limitations.  Firstly, the aim of this study is to 
develop a conceptual model of HIV-positive drug users’ experiences of taking HAART. 
However, due to a small number of female HIV-positive drug users in Taiwan (n=921) (CDC, 
2020) and the possible influence of social expectation towards the female gender, only three 
female participants agreed to take part in this study. Thus, the findings in this study may not 
be able to fully convey female HIV-positive drug users’ experiences of taking HAART. 
Secondly, structural factors, particularly infrastructural factors (e.g. accessibility of HAART), 
were not identified within the findings, and were not found to be the main concern for the 
majority of participants. Despite this, the conceptual framework developed in this study 
provides useful insight and is potentially transferable to other social contexts, offering 
opportunities to explore and examine the structural element. We recommend that further 
work is needed to examine the applicability of this model in different social contexts and 
develop an intervention based on this model to address the needs of this population and 
optimise their treatment adherence.  
What does this paper contribute to the wider global clinical 
community? 
 This study provides insight into HIV-positive drug users’ experiences of taking 
antiretroviral medications 
 The findings extend our knowledge on the complex interplay of HIV-positive drug 
users’ drug-taking and HAART-taking behaviour 
 The Identity-Value-Conscious engagement Model developed from this study can be 
applied to help understand behaviour change and maintenance in relation to 
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Table 1: Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Individuals are eligible to participate in the study if 
they are: 
1) HIV-positive 
2) at least 20 years old (individuals under 20 are 
under the care of a legal guardian in Taiwan) 
3) able to complete the interviews in  Mandarin  
4) illicit drug users (current and past) 
5) have been on HAART regimens 
Individuals are not eligible if they are:  
1) HIV-negative 
2) less than 20 years old  
3) not illicit drug users 
4) currently hospitalised or in prison 
5) unable to give informed consent 
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Table 3: Non-participation cases 
Missing Case Reason 
1 Missed appointments 
2 (Coupled with 3) Did not come to the appointment 
3 (Coupled with 2) Showed up in the outpatient setting 
unexpectedly and left quickly 
4 Hospitalised due to low CD4 cell 
counts 
5 (Coupled with 6) Could not reach her 
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Table 4: Interview guide 
Guideline for the semi-structured interviews  
 Self-introducing the interviewer (the first author) 
 Creating a comfortable and welcoming interview environment 
 
Questions guideline (interview questions may change based on participants’ answers)  
Initial questions: 
 Tell me about your experience with being HIV positive. 
Probe: What HIV means to you? What contributed to this feeling?  
 Tell me about your experience with drug misuse. 
Probe: How you feel about this? Why? How you managed? 
 How does being HIV-positive and drug use impact on your life?  
Probe: What happened? Under what conditions? How you managed?  
 Tell me about your experiences with HIV treatment?  
 What does HIV treatment mean to you? 
Probe: What contributed to this feeling? 
 How do you feel before and after taking this regimen (At beginning versus years later)?  
Probe: Tell me why your views and/or actions may have changed (if any)?  What have you learned? 
 Has there ever been a specific time when you haven’t taken your medication?  
Probe: 1) Why?  
            2) Please describe the situation.  
            3) What contributed to this change or continuity?  
            4) What helps you to manage? 
 Who and what support you throughout the treatment course?  
Ending questions 
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Table 5: Concept mapping 
Concept Category Sub-category 




Shame and self-stigma 
Non-disclosure of HIV status 
Integrated self-identity Accepting HIV status 
Selective disclosure of HIV status 
Feeling supported 
Values attached to HAART 
taking 
Placing low values on HAART taking Forming negative assumptions 
about HAART 
Not perceiving the 
importance/need of and 
disinterest  in regular HAART use  
Placing values on drugs more 
than HAART 
Developing the values of taking HAART Perceived benefits of HAART 
taking and perceived severity of 
erratic HAART use 
Having life aspirations 
Developing the mindset of 
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Figure 1: Conscious engagement as the key factor that sustained participants’ adherence to HAART 
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